SCHEMBL7658562

SCHEMBL7658562

CCOC(=O)N1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.68
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
NPSR1 Q6W5P4 1/20 0.68
SMN1; SMN2 Q16637 5/20 0.66
NPC1 O15118 3/20 0.66
RAB9A P51151 3/20 0.66
TSHR P16473 3/20 0.65
GAA P10253 3/20 0.65
CYP2C19 P33261 2/20 0.65
MAPT P10636 1/20 0.61
ALDH1A1 P00352 3/20 0.60
CYP1A2 P05177 1/20 0.60
POLB P06746 1/20 0.60
CYP2C9 P11712 1/20 0.60
HPGD P15428 1/20 0.58
F13A1 P00488 1/20 0.58
TGM2 P21980 1/20 0.58
TGM1 P22735 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970912 0.93 MEN1 (0.76) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL379160 0.93 MEN1 (0.76) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL4814264 0.93 MEN1 (0.76) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL7393652 0.93 MEN1 (0.76) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL15011579 0.91 MEN1 (0.73) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
Bicarbonate SCHEMBL4357688 0.91 MEN1 (0.73) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL31439570 0.91 L3MBTL1 (0.62) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL953327 0.89 MEN1 (0.62) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL10243152 0.89 MEN1 (0.62) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL15709327 0.89 L3MBTL1 (0.63) L3MBTL1MEN1KMT2ANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527270-B Medical intermediate of PROTAC molecule targeting monoacylglycerol lipase, preparation method and application 河南大学 2024-03-01 CN claimed
CN-113527270-B Medical intermediate of PROTAC molecule targeting monoacylglycerol lipase, preparation method and application 河南大学 2024-03-01 CN disclosed
US-6335341-B1 ANTICHOLESTEROL AGENTS; ATHEROSCLEROSIS ZENECA LIMITED (GB) 2002-01-01 US disclosed
EP-1000057-A1 PYRIDYL- AND PYRIMIDYL-HETEROCYCLIC COMPOUNDS INHIBITING OXIDO SQUALENE-CYCLASE AstraZeneca UK Limited (GB) 2000-05-17 EP disclosed
WO-1999006395-A1 PYRIDYL- AND PYRIMIDYL-HETEROCYCLIC COMPOUNDS INHIBITING OXIDO SQUALENE-CYCLASE ZENECA LIMITED (GB) 1999-02-11 WO disclosed